Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Epidemiology|October 18, 2002
Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screeneesBeatrice A Golomb, Leena Tenkanen, Tiina Alikoski, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary riskTiina Huittinen, Maija Leinonen, Leena Tenkanen, et al.International Journal of Cancer|April 12, 2002
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control studyPär Stattin, Herman Adlercreutz, Leena Tenkanen, et al.International Journal of Cancer|November 18, 2003
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countriesPentti Tuohimaa, Leena Tenkanen, Merja Ahonen, et al.International Journal of Cancer|December 4, 2003
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective studyPär Stattin, Sonja Lumme, Leena Tenkanen, et al.Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancerSonja Lumme, Leena Tenkanen, Hilde Langseth, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Chlamydial antibodies and risk of prostate cancerTarja Anttila, Leena Tenkanen, Sonja Lumme, et al.Annals of Medicine|May 5, 2009
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetesJaakko Niemi, Ville-Petteri Mäkinen, Jukka Heikkonen, et al.Acta Oncologica (Stockholm, Sweden)|April 24, 2007
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancersEero Pukkala, Aage Andersen, Göran Berglund, et al.Pageof 2